Key points are not available for this paper at this time.
Peritoneal dialysis (PD) serves as a pivotal treatment modality for stage V chronic kidney disease (CKD) patients. Among the complications associated with PD, peritonitis emerges as a paramount concern due to its direct correlation with heightened morbidity and mortality rates. A comprehensive understanding of the bacteriological profile specific to each dialysis service is imperative, facilitating the prompt initiation of accurate empirical treatment and averting the progression to peritoneal failure, subsequently necessitating a transition to hemodialysis.
Conceição et al. (Mon,) studied this question.